CytomX Therapeutics CTMX
NASDAQ CTMX
$2.49 -0.02 (-0.60%)
As of: Oct 21, 2026 · 10:09 AM EDT

CytomX Therapeutics (CTMX) EV to EBIT (2024 - 2025)

Updated

CytomX Therapeutics' (CTMX) EV to EBIT stood at 17.07 in Q3 2025, compared with -3.76 a year earlier and up 445.7% from the prior quarter.

Analysis

CytomX Therapeutics (CTMX) EV to EBIT (2024 - 2025) Analysis & Trends

On a TTM basis, CytomX Therapeutics' EV to EBIT came in at 2.51 as of Sep 30, 2025; for FY2024, it was -0.72.

  • Per Business Quant, the preceding three quarters came in at 3.13 (Q2 2025), -0.79 (Q1 2025) and -0.72 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,129.39 Bn 1,097.98 Bn 19.71 Bn
2 Johnson & Johnson 615.68 Bn 534.21 Bn 17.26 Bn
3 AbbVie 505.77 Bn 478.89 Bn 12.70 Bn
4 Merck 366.50 Bn 320.88 Bn 12.21 Bn
5 Novartis Ag 297.33 Bn 261.32 Bn 11.24 Bn
6 Astrazeneca 261.02 Bn 234.71 Bn 12.86 Bn
7 Amgen 235.47 Bn 190.87 Bn 7.24 Bn
8 Gilead Sciences 189.20 Bn 163.40 Bn 6.22 Bn
9 Pfizer 170.20 Bn 116.85 Bn 10.94 Bn
10 CytomX Therapeutics 547.35 Mn -410.32 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 17.07
Jun 30, 2025 3.13
Mar 31, 2025 -0.79
Dec 31, 2024 -0.72
Sep 30, 2024 -3.76
Jun 30, 2024 -7.32
Mar 31, 2024 2.64
API Access

CytomX Therapeutics EV to EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebit&ticker=CTMX&period=max&api_key=YOUR_API_KEY